Ocular Hypertension
Higher-than-average eye pressure with a healthy optic nerve and normal visual field — the single biggest risk factor for developing glaucoma, but not glaucoma itself.
Overview
Ocular hypertension means your eye pressure measures above the statistical average (generally above 21 mmHg) but your optic nerve looks healthy and your visual field testing is normal. It's best understood as a risk factor rather than a disease — similar to how high cholesterol is a risk factor for heart disease without meaning a heart attack has occurred.
Eye pressure by itself doesn't cause symptoms, so ocular hypertension is almost always found incidentally during a routine comprehensive eye exam. This is one of the main reasons regular eye exams matter even when your vision feels fine.
Symptoms
- No symptoms in the vast majority of people — elevated eye pressure alone does not hurt or blur vision
- Occasionally discovered only through a routine screening eye pressure check
- No visual field loss or optic nerve changes (by definition)
How Common Is It?
Depending on the population studied and the pressure cutoff used, ocular hypertension is estimated to affect roughly 3–7% of adults over age 40, making it considerably more common than glaucoma itself.
Most people with ocular hypertension never progress to glaucoma. The landmark Ocular Hypertension Treatment Study (OHTS) found that over about 5 years, only a minority of untreated patients developed glaucoma, though early treatment roughly cut that risk in half in higher-risk patients.
Genetics & Risk Factors
A family history of glaucoma increases the likelihood that elevated eye pressure will eventually cause optic nerve damage, suggesting an inherited susceptibility of the optic nerve or drainage system, even when no single gene is identified in most patients.
The strongest measurable risk factor identified by OHTS is a thinner-than-average central corneal thickness, which both makes standard pressure readings misleadingly low (the true pressure may be higher than measured) and appears to independently signal a more vulnerable optic nerve. Other recognized risk factors include older age, African ancestry, larger cup-to-disc ratio, and higher baseline eye pressure.
Ocular Findings on Exam
On exam, the hallmark of ocular hypertension is elevated intraocular pressure with an optic nerve that appears healthy: a normal-sized cup, intact neuroretinal rim, and no thinning on nerve fiber layer imaging. The drainage angle is open on gonioscopy.
Because the optic nerve and visual field are normal, the diagnosis is really one of exclusion — ruling out early glaucoma — which is why baseline imaging is so important.
Testing & Diagnosis
- Goldmann applanation tonometry (the gold-standard pressure measurement) on multiple visits
- Corneal pachymetry (measuring corneal thickness) to correct and interpret your pressure reading accurately
- OCT imaging of the optic nerve fiber layer to detect subtle damage not yet visible on exam
- Automated visual field testing to confirm there is no functional vision loss
- Gonioscopy to confirm the drainage angle is open
- Use of a validated risk calculator (such as the OHTS/EGPS risk model) combining these factors into a 5-year risk estimate
Treatment Options
Individualized Risk Assessment
Rather than treating every elevated pressure automatically, we calculate your personalized risk of progressing to glaucoma using validated models, then discuss the trade-offs of treating now versus monitoring.
Observation
For lower-risk patients, careful monitoring with periodic OCT and visual field testing (often every 6–12 months) is a reasonable and common approach.
Prostaglandin Analog Drops
When treatment is warranted, a once-daily prostaglandin drop is typically the first choice given its effectiveness and minimal systemic side effects.
Selective Laser Trabeculoplasty (SLT)
A quick in-office laser treatment that can lower pressure for higher-risk patients who prefer to avoid or reduce daily drops.
How This Differs From Other Glaucomas
Ocular hypertension is unique among the conditions on this page because it is a risk state, not a disease with active damage — the decision to treat is a calculated judgment call rather than an automatic response to a number.
Unlike glaucoma, where treatment is essentially never optional once damage is confirmed, ocular hypertension management often includes a legitimate 'watch and wait' option for lower-risk patients, with treatment reserved for those whose calculated risk of future damage is high enough to justify it.
Frequently Asked Questions
Is ocular hypertension the same as glaucoma?
No. Ocular hypertension means eye pressure above the statistically normal range, but with a healthy optic nerve and normal visual field. Glaucoma means the optic nerve has been damaged. Ocular hypertension is a risk state, not a diagnosis of disease.
Will I definitely get glaucoma?
No. Landmark research (the Ocular Hypertension Treatment Study, OHTS) followed thousands of patients and found that most people with ocular hypertension never develop glaucoma, though their risk is meaningfully higher than average.
How do you decide who needs treatment?
We weigh your eye pressure level, corneal thickness, optic nerve appearance, age, and family history using validated risk calculators, then discuss your individualized risk with you before deciding whether to treat or monitor.
What happens if I choose not to treat?
Many patients with lower calculated risk are safely monitored with periodic OCT imaging, visual fields, and pressure checks rather than started on drops immediately — treatment is not automatic.
See a glaucoma specialist. Dr. Robert Gunzenhauser is Harvard-educated and UCLA fellowship-trained in glaucoma, providing expert diagnosis and treatment for Ocular Hypertension at Inland Glaucoma Center in Upland, CA.